Angiotensin-(1-7) improves cognitive function in rats with chronic cerebral hypoperfusion

Area of Science:

• Neuroscience
• Pharmacology
• Gerontology

Background:

• Chronic cerebral hypoperfusion (CCH) is a significant factor in cognitive decline, particularly in aging, vascular dementia, and Alzheimer's disease.
• Angiotensin-(1-7) (Ang-(1-7)), a brain constituent, has demonstrated neuroprotective effects against cognitive dysfunction and ischemia.

Purpose of the Study:

• To investigate the therapeutic potential of Ang-(1-7) in mitigating cognitive deficits induced by CCH.
• To elucidate the underlying mechanisms of Ang-(1-7)'s neuroprotective effects in a rat model of CCH.

Main Methods:

• Rats were subjected to permanent bilateral common carotid artery occlusion to induce CCH.
• Cognitive function was assessed following Ang-(1-7) administration.
• Hippocampal tissue was analyzed for neuronal loss, astrocyte proliferation, and nitric oxide levels.

Main Results:

• Ang-(1-7) significantly ameliorated cognitive deficits in rats experiencing CCH.
• Treatment with Ang-(1-7) was associated with increased nitric oxide generation in the hippocampus.
• Neuroprotection was evidenced by attenuated neuronal loss and suppressed astrocyte proliferation.

Conclusions:

• Angiotensin-(1-7) demonstrates significant therapeutic potential for cognitive impairments linked to chronic cerebral hypoperfusion.
• The neuroprotective mechanisms involve enhanced nitric oxide signaling and reduced neuroinflammation.
• Ang-(1-7) represents a promising candidate for treating conditions like vascular dementia and age-related cognitive decline.